Skip to main content

SOPHiA GENETICS SA

SOPH
Exchange
Nasdaq
Industry
Services-Computer Processing & Data Preparation
SEC CIK
0001840706

In the last 90 days, SOPHiA GENETICS SA insiders filed 0 open-market purchases and 27 sales; 71 institutions reported holding it in 13F filings for Q2 2026, worth $212.5M in total; Akre Capital Management is the only superinvestor holding it.

Q1 2024 vs. Q4 2023

How the institutions holding SOPHiA GENETICS SA changed between Q4 2023 and Q1 2024.

All holders in Q1 2024All holders in Q4 2023

13F holders of SOPH: Q4 2023 compared with Q1 2024
MeasureQ4 2023Q1 2024Change
Holders3632−4
Shares17.2M17.5M+263.0K (+1.5%)
Value$81.2M$86.3M+$5.09M (+6.3%)

New holders (2)

Institutions that held SOPHiA GENETICS SA at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to SOPH in Q1 2024
InstitutionSharesValue% of portfolio
Akre Capital Management LLCSuperinvestorAkre Capital Management287,699$1.42M0.01%
Dimensional Fund Advisors LP12,354$60.9K0.00%

Sold out (6)

Institutions that held SOPHiA GENETICS SA at the end of Q4 2023 and filed for Q1 2024 without it.

Institutions that sold out of SOPH in Q1 2024
InstitutionShares, Q4 2023Value, Q4 2023
Pura Vida Investments, LLC284,724$1.34M
Privium Fund Management B.V.29,080$140.5K
Citadel Advisors LLC20,174$95.0K
JPMorgan Chase & Co881$4.15K
Tower Research Capital LLC (TRC)669$3.15K
Advisor Group Holdings, Inc.620$2.89K